Tbx1 Is the first dosage-sensitive gene identified in the DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), a congenital disorder characterized by neural-crest-related developmental defects. Here, TBX1 is linked to 22q11.2 deletion syndrome.